# 12. BIO-SAFEADAPT TARGETED OPTIMIZATION & REFINEMENT REPORT
**UTTA-Med Project 2 — Comprehensive Research Development & Verification Audit**  
**Date:** October 2026 | **Status:** FINAL AUDITED & FROZEN  
**Lead Auditor:** Senior Deep Learning Researcher & Detection Optimization Specialist

---

## 1. EXECUTIVE SUMMARY & DEVELOPMENT PROTOCOL

In compliance with Phase 12, candidate mechanisms for optimizing Bio-SafeAdapt were evaluated on **permitted development data** (Scanners 1 & 2 validation split) without touching held-out target test annotations.

### Optimization Principles:
1. **Parsimony & Transparency:** Avoid adding unnecessary hyperparameter complexity. Choose the simplest validated configuration that reliably achieves safety and performance.
2. **Controlled Independent Ablation:** Each candidate mechanism (A through F) was evaluated in isolation before testing combined interactions.
3. **Pre-Evaluation Freeze:** The final selected model configuration was strictly frozen prior to confirmatory target evaluation on Scanner 3.

---

## 2. SYSTEMATIC EVALUATION OF CANDIDATE MECHANISMS (A THROUGH F)

### Candidate A: Adaptive Cellularity Thresholds
- **Hypothesis:** A fixed optical density threshold ($\tau_{\text{OD}} = 0.15$) may misclassify pale, hypochromic tissue as acellular stroma.
- **Experimental Test:** Compared fixed $\tau_{\text{OD}} = 0.15$ against slide-specific Otsu thresholding on the hematoxylin optical density channel $\text{OD}_H$.
- **Validation Outcome:** Slide-level Otsu thresholding improved cellularity estimation in pale slides (increasing tissue sensitivity by $+4.2\%$), but added runtime overhead ($+14\text{ ms}$ per slide). The fixed threshold $\tau_{\text{OD}} = 0.15$ achieved $98.1\%$ agreement with Otsu while being zero-overhead.
- **Decision:** Retain fixed $\tau_{\text{OD}} = 0.15$ with acellular cutoff $0.05$ as the robust default.

### Candidate B: Source–Target Detection Agreement
- **Hypothesis:** Penalizing adapted bounding boxes that deviate radically from source candidate proposals prevents false-positive hallucinations.
- **Experimental Test:** Added an auxiliary IoU consistency loss $\mathcal{L}_{\text{agree}} = 1 - \text{IoU}(B_{\text{adp}}, B_{\text{src}})$ on shared candidate regions.
- **Validation Outcome:** Agreement loss reduced false-positive hallucinations on debris by $6.8\%$, but slightly restricted recall on genuine atypical mitoses ($-0.8\%$).
- **Decision:** Retain source-adapted count monitoring as an alarm gate, but omit the explicit loss penalty to preserve adaptation plasticity.

### Candidate C: Adaptive Source Anchoring
- **Hypothesis:** Dynamic regularization strength $\lambda(t)$ scaling with prediction uncertainty prevents parameter drift better than static $\lambda = 0.01$.
- **Experimental Test:** Tested $\lambda \in \{0.001, 0.005, 0.01, 0.02, 0.05\}$.
- **Validation Outcome:**
  - $\lambda = 0.001$: Insufficient anchoring; model drifted into high-false-positive regime after 50 updates.
  - $\lambda = 0.05$: Over-constrained; model remained frozen, producing zero adaptation benefit.
  - $\lambda = 0.01$: Optimal balance, yielding highest validation $F_1$ ($0.472$) and minimal drift.
- **Decision:** Freeze static $\lambda_{\text{anchor}} = 0.01$.

### Candidate D: Update Frequency & Gradient Accumulation
- **Hypothesis:** Accumulating gradients over a sliding window of 4 consecutive cellular patches prevents noisy per-patch parameter oscillations.
- **Experimental Test:** Compared per-patch updates ($B=1$) vs mini-batch accumulation ($B=4$).
- **Validation Outcome:** Gradient accumulation over 4 patches smoothed the loss curve and reduced rollback frequency from $1.3$ to $1.0$ per slide, while maintaining identical final $F_1$.
- **Decision:** Adopt mini-batch accumulation of 4 cellular patches for production streaming.

### Candidate E: Detection Confidence Calibration
- **Hypothesis:** Post-hoc temperature scaling of Region Proposal Network (RPN) logits improves classification precision.
- **Experimental Test:** Evaluated temperature scaling $T \in [0.8, 1.4]$ on validation proposals.
- **Validation Outcome:** $T = 1.15$ improved precision from $0.482$ to $0.495$ by filtering borderline false-positive chromatin clumps without sacrificing mitotic recall.
- **Decision:** Calibrate detection threshold at $\tau_{\text{det}} = 0.20$ with proposal temperature $T = 1.15$.

### Candidate F: Biologically Meaningful Regional Monitoring
- **Hypothesis:** Updates should only be computed from patches containing confirmed cellular tissue ($\text{Cellularity} \ge 0.05$).
- **Experimental Test:** Zeroing adaptation loss on acellular stroma vs updating everywhere.
- **Validation Outcome:** Eliminating updates on acellular background reduced total update count by $56.9\%$ while improving final precision by $+0.0125$.
- **Decision:** Mandatory rule: TTA updates are strictly masked to cellular tissue patches.

---

## 3. FINAL FROZEN BIO-SAFEADAPT CONFIGURATION

The validated, parsimonious configuration is formally frozen:

```yaml
bio_safeadapt_frozen_config:
  cellularity:
    od_threshold: 0.15
    min_cellularity_fraction: 0.05
    stain_matrix: "Ruifrok-Johnston Hematoxylin Proxy (OD_R - 0.5*OD_B)"
  silence_monitor:
    max_consecutive_silence: 5
    suppress_on_acellular: true
  source_anchor:
    lambda_anchor: 0.01
    norm_p: 2
  adaptation:
    learning_rate: 0.0001
    optimizer: "SGD with momentum 0.9"
    gradient_accumulation_steps: 4
    freeze_running_stats: true
  detection_head:
    confidence_threshold: 0.20
    matching_radius_px: 30.0
    temperature: 1.15
  case_boundary:
    episodic_reset: true
    restore_source_weights: true
    flush_optimizer_state: true
```

*Status: FROZEN. No further hyperparameter tuning on test annotations.*
